-
Professor Man Li: TROP-2 ADC Combined with PD-1 Immunotherapy—SACI-IO HR+ Study Faces Challenges but Offers Valuable Insights| Man Talks Breast Cancer: ASCO Special
In this “Man Talks Breast Cancer: ASCO Special,” Professor Man Li’s team from The Second Affiliated Hospital of Dalian Medical University has selected the latest ASCO studies on HR+ advanced breast cancer, covering topics such as cross-line treatment with CDK4/6 inhibitors, novel ADCs combined with ICIs, and comparing CDK4/6 inhibitors + ET with chemotherapy in…
-
ASCO 2024丨Advances in Acute Myeloid Leukemia (AML) Treatment
Acute myeloid leukemia (AML) is a highly heterogeneous hematologic malignancy, presenting significant challenges in treatment strategies and prognosis management for clinicians. At this year’s ASCO conference, several AML studies were presented. This article highlights three of them, covering the importance of frailty assessment, exploration of shortened treatment regimens, and interim results of new therapeutic agents.…
-
Analysis of Clinical Characteristics and Prognostic Model Construction for Prostate Cancer Patients with a History of Malignancy by Professor Kan Gong ‘s Team | AUA 2024
With advancements in cancer screening, diagnosis, and treatment, the survival period of cancer patients has significantly increased. Long-term management of cancer patients should not only focus on the primary tumor but also monitor for the occurrence of secondary primary tumors (SPTs) and multiple primary tumors through regular check-ups and screenings. Secondary primary tumors are defined…
-
EHA Expert Commentary | Professor Bingcheng Liu: Establishment of a Prognostic Scoring System for Blast Phase Chronic Myeloid Leukemia – Insights from the European Leukemia Network Blast Phase Registry Study
Chronic myeloid leukemia (CML) has a reliable prognostic scoring system during the chronic phase, but blast phase (BP) lacks comprehensive analysis of prognostic factors or standardized scoring systems. Despite the era of tyrosine kinase inhibitors (TKIs), outcomes for BP patients remain poor. From June 13 to 16, 2024, the 29th European Hematology Association (EHA) Annual…
-
EHA 5-Minute Highlights丨Professor Zonghong Shao: Advances in New Drug Treatments for Myelodysplastic Syndromes (MDS)
The treatment journey for Myelodysplastic Syndromes (MDS) is fraught with challenges due to its heterogeneity, hematopoietic failure, complications, and transformation risks, all of which significantly complicate therapy. Notably, the 29th Annual Meeting of the European Hematology Association (EHA 2024), held from June 13 to 16, 2024, showcased significant progress in the field of MDS treatment.…
-
Professor Zhitao Ying: Advances in Diagnosis and Treatment of Mantle Cell Lymphoma | 2024 Nanjing Lymphoma Forum
Mantle Cell Lymphoma (MCL) is a type of B-cell non-Hodgkin lymphoma (B-NHL) characterized by both the rapid progression of aggressive lymphomas and the incurability of indolent lymphomas, resulting in generally poor prognosis. At the recent “2024 Nanjing Lymphoma Forum,” Professor Zhitao Ying from the Cancer Hospital of the Chinese Academy of Medical Sciences delivered an…
-
Copy of Profound Insights from Professor Xiaofan Zhu on Team’s EHA-Selected Research – Children’s Leukemia
Currently, the field of pediatric leukemia treatment faces numerous challenges, particularly in predicting relapse risk and developing treatment strategies for relapsed and refractory patients. At the upcoming 29th European Hematology Association (2024 EHA) Annual Meeting, several studies from Professor Xiaofan Zhu’s team from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical…
-
Copy of ASCO China Voice | Professor Pei Dong Leads Multiple Breakthrough Studies at the ASCO Conference
The 60th Annual Meeting of the American Society of Clinical Oncology (ASCO) was grandly held in Chicago, USA, from May 31 to June 4, 2024. As a premier global event, ASCO gathers oncology experts from around the world to discuss the latest advancements and future trends in the field. At this year’s ASCO conference, several…
Connecting Medical Expertise through Media